Drawing for VITALANT

USPTO serial 87743963

VITALANT

Reviewed by CopyMark Law Group

Reg. 5657555Status 702Registered
Filing date
Status date
Registration date
Jan 15, 2019
Examiner
BRECKENFELD, WILLIAM G
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with VITALANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Emily A. Bayton

Emily A. Bayton FAEGRE DRINKER BIDDLE & REATH LLP1144 15th Street, Suite 3400Denver, CO 80202United States

Goods and services

ClassDescriptionStatusFirst use
035Inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices; promoting public awareness of the need for blood donors, namely, public awareness about blood products and community blood bank centers; arranging procurement of goods for others in the field of human bone, tissue, and organs for purposes of transplantation; and distributorship services in the field of human blood and blood products, therapeutic plasma-derivatives and recombinant coagulation productsACTIVESep 24, 2018
036Charitable fundraising services in the field of human blood and blood products to support blood bank operations and research in the field of transfusion medicineACTIVESep 24, 2018
039Storage of human bone, tissue, and organs for purposes of transplantationACTIVESep 24, 2018
040Processing of human bone, tissue and organs for purposes of transplantationACTIVESep 24, 2018
041Educational services, namely, providing educational materials to the general public and health care professionals about blood donation and transfusion; providing training and continuing professional education courses in the field of health, safety, medicine, immunology, blood banking, transfusion and human resources and business management in the transfusion medicine and blood banking laboratory fieldsACTIVESep 24, 2018
042Laboratory, clinical and translational research in the field of transfusion medicine, and infectious disease; blood analysis services; medical blood laboratory services; medical research in the field of blood; and providing quality assurance services in the field of blood and blood productsACTIVESep 24, 2018
044Blood bank services, namely, collection, supply, preservation, distribution, and coordination of human blood and blood products; organ and tissue bank services; medical testing of blood; blood bank services, namely, processing of bloodACTIVESep 24, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 3, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 3, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 13, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jan 15, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 26, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 26, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 13, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 15, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 11, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 10, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 19, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 19, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 29, 2018IUAFUSE AMENDMENT FILED—
Oct 29, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 23, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 28, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 28, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 8, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 20, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 18, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 8, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 25, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Apr 24, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 24, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 24, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 13, 2018DOCKASSIGNED TO EXAMINER—
Jan 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 8, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance